Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Sirgo

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
DICP : the Annals of Pharmacotherapy|March 1, 1991
Ceftazidime in the elderly: appropriateness of twice-daily dosingM A Sirgo, S Norris
Archives of Internal Medicine|December 1, 1988
Effects of antihypertensive agents on circadian blood pressure and heart rate patterns. ReviewM A Sirgo, R J Mills, V DeQuattro
Clinical Pharmacokinetics|December 1, 1989
Effects of age on the elimination of labetalolM L Rocci, T Valiquett, M A Sirgo
Pharmacotherapy|January 1, 1989
Treatment of hypertension in the elderly with labetalolM A Sirgo, B K Boyd, W B Applegate
American Journal of Therapeutics|November 13, 2001
Nonprescription doses of ranitidine are effective in the relief of episodic heartburnA A Ciociola, K A Pappa, M A Sirgo
Journal of Clinical Pharmacology|January 1, 1993
The safety of ranitidine in elderly versus non-elderly patientsM A Sirgo, R Mills, A R Euler, et al.
The Annals of Pharmacotherapy|July 1, 1993
Ceftazidime dosing in the elderly: economic implicationsP H Vlasses, W A Bastion, R Behal, et al.
Neurology|September 1, 1984
Interpretation of serum phenytoin concentrations in uremia is assay-dependentM A Sirgo, P J Green, M L Rocci, et al.
Clinical Pharmacology and Therapeutics|October 1, 1990
Comparative evaluation of the effects of isradipine and diltiazem on antipyrine and indocyanine green clearances in elderly volunteersP M Klockowski, M E Lener, M A Sirgo, et al.
American Journal of Therapeutics|November 13, 2001
A study of the nonprescription drug consumer's understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburnA A Ciociola, M A Sirgo, K A Pappa, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
DICP : the Annals of Pharmacotherapy|March 1, 1991
Ceftazidime in the elderly: appropriateness of twice-daily dosingM A Sirgo, S Norris
Archives of Internal Medicine|December 1, 1988
Effects of antihypertensive agents on circadian blood pressure and heart rate patterns. ReviewM A Sirgo, R J Mills, V DeQuattro
Clinical Pharmacokinetics|December 1, 1989
Effects of age on the elimination of labetalolM L Rocci, T Valiquett, M A Sirgo
Pharmacotherapy|January 1, 1989
Treatment of hypertension in the elderly with labetalolM A Sirgo, B K Boyd, W B Applegate
American Journal of Therapeutics|November 13, 2001
Nonprescription doses of ranitidine are effective in the relief of episodic heartburnA A Ciociola, K A Pappa, M A Sirgo
Journal of Clinical Pharmacology|January 1, 1993
The safety of ranitidine in elderly versus non-elderly patientsM A Sirgo, R Mills, A R Euler, et al.
The Annals of Pharmacotherapy|July 1, 1993
Ceftazidime dosing in the elderly: economic implicationsP H Vlasses, W A Bastion, R Behal, et al.
Neurology|September 1, 1984
Interpretation of serum phenytoin concentrations in uremia is assay-dependentM A Sirgo, P J Green, M L Rocci, et al.
Clinical Pharmacology and Therapeutics|October 1, 1990
Comparative evaluation of the effects of isradipine and diltiazem on antipyrine and indocyanine green clearances in elderly volunteersP M Klockowski, M E Lener, M A Sirgo, et al.
American Journal of Therapeutics|November 13, 2001
A study of the nonprescription drug consumer's understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburnA A Ciociola, M A Sirgo, K A Pappa, et al.
Pageof 3